HomeHome SearchSearch MenuMenu Our productsOur products

Pharmaceuticals

  • 5 Industries I'm buying during the COVID-19 Pandemic
  • Q. “With the number of infection and death rates picking up, there are talks that the second Coronavirus wave has already started. I'd like to know if there are any specific industries you're looking at buying which don't have a major effect on the pandemic?”     A. Yes, I have seen the COVID-19 levels up as well. I believe this is due to, countries opening the economies, allowi... ››› more
  • [29 July 2020]
  • Profit from sectors providing Covid 19 Solutions
  • The final theme in our 6-part series is Healthcare and Pharmaceuticals. While the global pandemic seems to be “under control” and vaccine trials on the go, there's a continued focus on healthcare, hospitals and medication. These form part of a defensive sector that is generally less cyclical. In preparation for an increase in Covid-19 patients the healthcare sector ramped up medical e... ››› more
  • [09 June 2020]
  • About the company: Ascendis Health Ltd [JSE:ASC]
  • Ascendis Health is a health and care brand company. It has a listing on the Johannesburg Stock Exchange… Full name: Ascendis Health Limited Short name: Ascendis Ticker: ASC Sector: Health care – pharmaceuticals & biotechnology         Five top facts about Ascendis Health Fact #1: Ascendis Health employs over 1,400 people across its operations. Fact #2: Ascendis Health... ››› more
  • [22 September 2014]
  • Brian Joffe takes over as chairman at Adcock Ingram
  • Last week, Adcock Ingram's biggest shareholders forced the then current chairman to step down from his position. This happened after the Public Investment Corporation (PIC) and Bidvest substantially increased their stakes in the local drug maker. Both requested Brian Joffe, CEO of Bidvest, take on the role. And today, news confirmed that Mr Joffe is now the new chairman of Adcock. Let's take a clo... ››› more
  • [26 February 2014]
  • CFR drops its bid as Bidvest stocks up on Adcock shares
  • Since Chilean firm, CFR Pharmaceuticals, first noted its interest in local drug maker Adcock Ingram, it was anything but plain sailing. The final nail in the buyout coffin was Bidvest's move to buy as many Adcock shares as it could get its hand on. Not surprisingly, CFR has now dropped its bid for Adcock. Let's take a closer look at what went on… On Friday, CFR announced what the market expect... ››› more
  • [10 February 2014]
  • Where to now for the Adcock buyout?
  • On Friday, it emerged that Bidvest had drastically increased its stake in local drug maker Adcock Ingram. The moves sees Bidvest owning more than 30% of Adcock. Last year, CFR Pharmaceuticals made an offer to buy Adcock, but with this move by Bidvest, it doesn't look likely now. Let's take a closer look at what's happening… In November, CFR Pharmaceuticals made a formal bid to buy Adcock Ingra... ››› more
  • [03 February 2014]
  • Bidvest soaks up as many Adcock shares as it can get its hands on
  • Yesterday, Bidvest purchased a huge amount of shares traded in Adcock Ingram. Reports suggest that it could be close to the 39 million traded on the day. This move by Bidvest means its stake in Adcock is rapidly growing. Shares in Adcock fell this morning. Let's take a closer look at what's going on… Back in November last year, Adcock Ingram received a formal bid from the Chilean drug firm CFR... ››› more
  • [31 January 2014]
  • Adcock delays buyout vote again
  • Earlier today, Adcock Ingram said it will likely postpone again the shareholder meeting to vote about the possible buyout of the company. Chilean firm, CFR Pharmaceuticals, made a formal bid for the drug maker last year. This is the second delay of the meeting. Let's take a closer look at what's going on… Adcock “expects to further delay until mid-February a shareholder vote” on the takeov... ››› more
  • [09 January 2014]
  • The PIC won't budge on its decision over Adcock
  • Earlier today, the Public Investment Corporation (PIC) said that it is still opposed to the buyout of Adcock Ingram by CFR Pharmaceuticals. The PIC is resolute that it doesn't want shares in CFR as part of the deal. Let's take a closer look at what's going on… On Sunday, the PIC rejected a revised bid by Chilean firm CFR. The PIC said that it is only interested in a cash only offer. And the... ››› more
  • [20 December 2013]
  • The PIC reject a revised offer by CFR for Adcock
  • On Sunday, the Public Investment Corporation (PIC) rejected a revised offer by the Chilean firm, CFR Pharmaceuticals for Adcock Ingram. This follows CFR increasing its offer by more than a R1 a share. But the PIC are still not happy with the deal. Let's take a closer look at what's going on… Since CFR Pharmaceuticals made a formal bid for Adcock Ingram in mid-November, the potential deal has m... ››› more
  • [17 December 2013]
  • The CFR takeover bid is under threat as Bidvest offers to buy a third of Adcock
  • Earlier today, Bidvest Group released a statement saying that it had put in an offer to buy one third of Adcock Ingram. Bidvest along with Community Investment Holdings (CIH) have bid $393 million for a chunk of Adcock shares. The new offer puts the bid by Chilean firm CFR Pharmaceuticals at risk. Let's take a closer look at the new offer… Today, Bidvest “offered to buy about a third of loca... ››› more
  • [02 December 2013]
  • The government adds some hope to the Adcock bid
  • The Department of Trade and Industry says that for the bid for local drug maker Adcock Ingram should include certain factors. This follows Chile's CFR Pharmaceuticals $1.2 billion bid for Adcock on 18 November. Let's take a closer look at what's going on… Yesterday, the Department of Trade and Industry said that the potential takeover of Adcock by CFR needs to meet a couple of factors, reports... ››› more
  • [28 November 2013]
  • High costs and a weak rand take their toll on Adcock's financial performance
  • Earlier today, Adcock Ingram Holdings Ltd released its results for the full year to the end of September. After warning the market last week that earnings would be down, today's results confirmed this. With the deal with CFR Pharmaceuticals still a possibility, Adcock suspended its dividend payment. Let's take a closer look at what the results revealed… Adcock, SA’s second largest drug maker... ››› more
  • [27 November 2013]
  • Bidvest complained to the JSE about Adcock last week
  • Last Tuesday, it emerged that a shareholder in Adcock Ingram complained to the JSE. The letter of complaint said that Adcock misled shareholders over the support backing the potential buyout deal by CFR Pharmaceuticals. Today it emerged that the complainant was Bidvest Group. Let's take a closer look at what's going on… Bidvest “complained to the JSE that Adcock misrepresented the level of s... ››› more
  • [25 November 2013]
  • The JSE receives a complaint alleging Adcock misled shareholders over buyout
  • Late yesterday, it emerged the JSE received a complaint from a disgruntled shareholder of Adcock Ingram. The shareholder claims that Adcock misled its shareholders about the level of support for the buyout deal by Chilean firm, CFR Pharmaceuticals. Let's take a closer look at what's going on… The JSE received a complaint from a shareholder in Adcock yesterday, says IOL. The complaint accuses A... ››› more
  • [20 November 2013]
  • CFR make a formal offer to buy Adcock
  • Four months after making an informal bid for local drug maker Adcock Ingram, CFR Pharmaceuticals placed a formal bid on the table on Friday. The shares rose on the news. But it's uncertain whether the deal will go through. Let's take a closer look at what's going on… Friday saw Chilean drug maker CFR making a “firm R12.6 billion offer” to buy Adcock, says IOL. This formal offer consists of... ››› more
  • [18 November 2013]
  • CFR see the PIC's rejection of its plan to buy Adcock as problematic
  • Yesterday, the CEO of CFR Pharmaceuticals, the Chilean company planning to buyout Adcock Ingram, arrived in Johannesburg. Alejandro Weinstein says that the Public Investment Corporation (PIC) refusing to back the deal is problematic and their support is desirable. It looks like there is a possibility that CFR could walk away from the deal without the PIC's backing. Let's take a closer look at what... ››› more
  • [12 November 2013]
  • Adcock is determined to go ahead with buyout
  • After the Public Investment Corporation (PIC) said it doesn't back the bid by CFR Pharmaceuticals, Adcock Ingram says it still wants to pursue the deal. Adcock's board believes that the deal is in the best interests of its shareholders. Let's take a closer look at what's going on… Adcock’s board says that “a $1.3 billion takeover from Chile’s CFR was in the best interest of all sharehold... ››› more
  • [08 November 2013]
  • Adcock shares plunge 4.54% as the PIC refuses to back buyout
  • The planned buyout of Adcock Ingram by Chilean firm CFR Pharmaceuticals took a blow yesterday when Adcock's largest shareholder said it would not back the deal. The Public Investment Corporation said that the deal isn't in investors' interests. Shares in Adcock tumbled on the news. Let's take a closer look at what's going on… Yesterday afternoon, the Public Investment Corporation (PIC) said th... ››› more
  • [07 November 2013]
  • Adcock shares rise as 45% of shareholders vote yes to a buyout
  • Earlier today, Adcock Ingram announced that about 45% of its shareholders were for a buyout by Chilean firm CFR Pharmaceuticals. Shares in Adcock rose on the news. After the chance of a buyout deal emerged nearly four months ago, the signs are still positive that it will go ahead. Let's take a closer look at what Adcock said today… Adcock Ingram, South Africa’s second biggest drug maker, sai... ››› more
  • [30 October 2013]
Page: 1 2 »


Trending Topics